NASDAQ:NRXS NeurAxis (NRXS) Stock Price, News & Analysis → Urgent dollar warning (From Stansberry Research) (Ad) Free NRXS Stock Alerts $3.30 0.00 (0.00%) (As of 05/2/2024 ET) Add Compare Share Share Today's Range$3.15▼$3.3050-Day Range$2.82▼$3.7052-Week Range$1.80▼$6.93Volume2,674 shsAverage Volume10,611 shsMarket Capitalization$21.75 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsSocial Media Get NeurAxis alerts: Email Address Ad StockEarningsThe AI Stock that’s Disrupting Every IndustryMove over Nvidia. There’s a new hot AI play that has soared 960% in the past year. One high-flying artificial intelligence stock has soared 960% over the past year and may soon become as familiar as Nvidia…Here's the Ticker >>> About NeurAxis Stock (NASDAQ:NRXS)NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.Read More NRXS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NRXS Stock News HeadlinesMay 1, 2024 | americanbankingnews.comCritical Review: NeurAxis (NRXS) and Its PeersApril 24, 2024 | americanbankingnews.comCritical Analysis: NeurAxis (NRXS) vs. Its PeersMay 3, 2024 | Paradigm Press (Ad)Dems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.April 23, 2024 | globenewswire.comNeurAxis Announces New Medical Policy Coverage in North DakotaApril 23, 2024 | americanbankingnews.comAnalyzing NeurAxis (NRXS) and Its CompetitorsApril 12, 2024 | finance.yahoo.comNeurAxis, Inc. (NASDAQ:NRXS) Q4 2023 Earnings Call TranscriptApril 11, 2024 | finanznachrichten.deNeurAxis, Inc.: NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsApril 11, 2024 | seekingalpha.comNeurAxis, Inc. (NRXS) Q4 2023 Earnings Call TranscriptMay 3, 2024 | Paradigm Press (Ad)Dems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.April 9, 2024 | globenewswire.comNeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsApril 1, 2024 | globenewswire.comNeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024March 27, 2024 | globenewswire.comNeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center RegistryMarch 11, 2024 | globenewswire.comNeurAxis Announces Highmark BCBS Policy CoverageMarch 4, 2024 | globenewswire.comNeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy CoverageFebruary 27, 2024 | globenewswire.comNeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceFebruary 1, 2024 | au.finance.yahoo.comNeurAxis, Inc. (NRXS)January 31, 2024 | finanznachrichten.deNeurAxis, Inc.: NeurAxis Appoints Timothy Henrichs as Chief Financial OfficerJanuary 31, 2024 | finance.yahoo.comNeurAxis Appoints Timothy Henrichs as Chief Financial OfficerDecember 20, 2023 | finanznachrichten.deNeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive OfficerDecember 20, 2023 | finance.yahoo.comNeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive OfficerNovember 21, 2023 | finanznachrichten.deNeurAxis, Inc.: NeurAxis Reports Third Quarter 2023 Financial ResultsNovember 21, 2023 | msn.comNeurAxis reports Q3 resultsNovember 20, 2023 | finance.yahoo.comNeurAxis Reports Third Quarter 2023 Financial ResultsNovember 15, 2023 | finance.yahoo.comNeurAxis Announces CareFirst BCBS Policy CoverageNovember 14, 2023 | msn.comNeurAxis secures $3M financing through preferred stock offeringNovember 14, 2023 | finance.yahoo.comNeurAxis Secures $3 Million FinancingNovember 8, 2023 | finance.yahoo.comNeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal DeviceSee More Headlines Receive NRXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeurAxis and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/16/2024Today5/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:NRXS CUSIPN/A CIK1933567 Webneuraxis.com Phone(812) 689-0791FaxN/AEmployees17Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($4.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,630,000.00 Net Margins-594.55% Pretax Margin-594.59% Return on EquityN/A Return on Assets-899.27% Debt Debt-to-Equity RatioN/A Current Ratio0.13 Quick Ratio0.12 Sales & Book Value Annual Sales$2.46 million Price / Sales8.84 Cash FlowN/A Price / Cash FlowN/A Book Value($0.27) per share Price / Book-12.22Miscellaneous Outstanding Shares6,590,000Free FloatN/AMarket Cap$21.75 million OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Brian Carrico (Age 42)President, CEO & Director Comp: $373.58kDr. Adrian Miranda (Age 54)Senior VP of Science & Technology and Chief Medical Officer Comp: $266.35kDr. Christopher Robin Brown D.D.S. (Age 70)Founder, Director of Innovation & Director Key CompetitorsQT ImagingNASDAQ:QTIMovanoNASDAQ:MOVEBioSig TechnologiesNASDAQ:BSGMelectroCoreNASDAQ:ECORPixie Dust TechnologiesNASDAQ:PXDTView All Competitors NRXS Stock Analysis - Frequently Asked Questions Should I buy or sell NeurAxis stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for NeurAxis in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" NRXS shares. View NRXS analyst ratings or view top-rated stocks. How have NRXS shares performed in 2024? NeurAxis' stock was trading at $2.67 at the start of the year. Since then, NRXS stock has increased by 23.6% and is now trading at $3.2999. View the best growth stocks for 2024 here. How were NeurAxis' earnings last quarter? NeurAxis, Inc. (NASDAQ:NRXS) posted its quarterly earnings results on Tuesday, April, 16th. The company reported $0.29 earnings per share for the quarter. The company earned $0.53 million during the quarter. When did NeurAxis IPO? NeurAxis (NRXS) raised $7 million in an initial public offering on Wednesday, August 9th 2023. The company issued 1,098,667 shares at a price of $6.00 per share. How do I buy shares of NeurAxis? Shares of NRXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NRXS) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldThe AI stock to buy right nowStockEarningsCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetry$5,000 Gold?Stansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour bank is lying to you.MyBankTracker Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeurAxis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
